Baxter Total Liabilities and Share Holders Equity 2010-2024 | BAX
Baxter total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Baxter total liabilities and share holders equity for the quarter ending December 31, 2024 was $25.782B, a 8.82% decline year-over-year.
- Baxter total liabilities and share holders equity for 2024 was $25.782B, a 8.82% decline from 2023.
- Baxter total liabilities and share holders equity for 2023 was $28.276B, a 0.04% decline from 2022.
- Baxter total liabilities and share holders equity for 2022 was $28.287B, a 15.61% decline from 2021.
| Baxter Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $25,782 |
| 2023 | $28,276 |
| 2022 | $28,287 |
| 2021 | $33,521 |
| 2020 | $20,019 |
| 2019 | $18,193 |
| 2018 | $15,720 |
| 2017 | $17,111 |
| 2016 | $15,546 |
| 2015 | $20,962 |
| 2014 | $26,138 |
| 2013 | $25,224 |
| 2012 | $20,390 |
| 2011 | $19,073 |
| 2010 | $17,489 |
| 2009 | $17,354 |
| Baxter Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-12-31 | $25,782 |
| 2024-09-30 | $26,676 |
| 2024-06-30 | $26,312 |
| 2024-03-31 | $27,788 |
| 2023-12-31 | $28,276 |
| 2023-09-30 | $30,656 |
| 2023-06-30 | $27,885 |
| 2023-03-31 | $28,291 |
| 2022-12-31 | $28,287 |
| 2022-09-30 | $27,965 |
| 2022-06-30 | $31,831 |
| 2022-03-31 | $32,716 |
| 2021-12-31 | $33,521 |
| 2021-09-30 | $19,807 |
| 2021-06-30 | $19,682 |
| 2021-03-31 | $19,466 |
| 2020-12-31 | $20,019 |
| 2020-09-30 | $20,098 |
| 2020-06-30 | $19,465 |
| 2020-03-31 | $19,075 |
| 2019-12-31 | $18,193 |
| 2019-09-30 | $17,299 |
| 2019-06-30 | $17,544 |
| 2019-03-31 | $16,350 |
| 2018-12-31 | $15,720 |
| 2018-09-30 | $16,847 |
| 2018-06-30 | $16,578 |
| 2018-03-31 | $16,890 |
| 2017-12-31 | $17,111 |
| 2017-09-30 | $17,541 |
| 2017-06-30 | $16,963 |
| 2017-03-31 | $15,659 |
| 2016-12-31 | $15,546 |
| 2016-09-30 | $15,795 |
| 2016-06-30 | $15,982 |
| 2016-03-31 | $17,350 |
| 2015-12-31 | $20,962 |
| 2015-09-30 | $20,172 |
| 2015-06-30 | $30,015 |
| 2015-03-31 | $24,861 |
| 2014-12-31 | $26,138 |
| 2014-09-30 | $25,563 |
| 2014-06-30 | $25,629 |
| 2014-03-31 | $25,261 |
| 2013-12-31 | $25,224 |
| 2013-09-30 | $25,250 |
| 2013-06-30 | $23,751 |
| 2013-03-31 | $20,318 |
| 2012-12-31 | $20,390 |
| 2012-09-30 | $19,825 |
| 2012-06-30 | $18,446 |
| 2012-03-31 | $18,784 |
| 2011-12-31 | $19,073 |
| 2011-09-30 | $17,843 |
| 2011-06-30 | $17,741 |
| 2011-03-31 | $17,413 |
| 2010-12-31 | $17,489 |
| 2010-09-30 | $17,563 |
| 2010-06-30 | $16,487 |
| 2010-03-31 | $17,166 |
| 2009-12-31 | $17,354 |
| 2009-09-30 | $16,954 |
| 2009-06-30 | $15,743 |
| 2009-03-31 | $14,953 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $14.818B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |